Relay Therapeutics (RLAY) Non-Current Assets (2020 - 2025)
Historic Non-Current Assets for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to $46.0 million.
- Relay Therapeutics' Non-Current Assets fell 2923.71% to $46.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $216.2 million, marking a year-over-year decrease of 2235.46%. This contributed to the annual value of $62.1 million for FY2024, which is 1595.22% down from last year.
- According to the latest figures from Q3 2025, Relay Therapeutics' Non-Current Assets is $46.0 million, which was down 2923.71% from $48.4 million recorded in Q2 2025.
- In the past 5 years, Relay Therapeutics' Non-Current Assets registered a high of $81.4 million during Q3 2022, and its lowest value of $28.9 million during Q1 2021.
- In the last 5 years, Relay Therapeutics' Non-Current Assets had a median value of $62.1 million in 2024 and averaged $57.0 million.
- In the last 5 years, Relay Therapeutics' Non-Current Assets skyrocketed by 15164.11% in 2022 and then crashed by 2923.71% in 2025.
- Quarter analysis of 5 years shows Relay Therapeutics' Non-Current Assets stood at $32.2 million in 2021, then soared by 149.27% to $80.3 million in 2022, then decreased by 7.96% to $73.9 million in 2023, then dropped by 15.95% to $62.1 million in 2024, then fell by 25.94% to $46.0 million in 2025.
- Its Non-Current Assets was $46.0 million in Q3 2025, compared to $48.4 million in Q2 2025 and $59.7 million in Q1 2025.